A new test could save arthritis patients time, money, and pain. But will it be used?

Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class.

Johnson & Johnson sees highest filings and grants during August in Q3 2023

Share this article Johnson & Johnson has been focused on protecting inventions in United States(US) with 793 publications in Q3 2023 The United States(US) Patent

November 24, 2023

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (342) Novartis (237) Merck (187) AstraZeneca (181) Pfizer (177) F. Hoffmann-La Roche (164) AbbVie (148) Eli Lilly

February 16, 2024

Mechanically ventilated patients in intermediate care units of rural hospitals have higher death rates

A new National Institutes of Health-supported study finds that patients receiving ventilator life support in the intermediate care units – a potentially less costly alternative

January 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.